
Articles
-
Aug 7, 2024 |
thelancet.com | Elizabeth Gourd
National Institute for Health and Care Excellence (NICE) have been unable to recommend trastuzumab deruxtecan (Enhertu) as a cost-effective treatment for patients with advanced HER2-low breast cancer being treated by NHS England, according to final published guidance released on July 29, 2024.
-
Jun 25, 2024 |
thelancet.com | Elizabeth Gourd
The content on this site is intended for science and health care professionals. We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Settings for this site. All content on this site: Copyright © 2024 Elsevier Ltd., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
-
Jun 6, 2024 |
thelancet.com | Elizabeth Gourd
Thousands of patients were given blood contaminated with HIV, hepatitis C, and other infections over a 21-year period, in what has been termed by Lord Winston “the worst treatment disaster in NHS history”, according to the results of the Infected Bloody Inquiry. The Inquiry's final report, published on May 20, 2024, has confirmed that across the UK, more than 3000 deaths have resulted from infected blood and blood products that were given to patients between 1970 and 1991.
-
May 1, 2024 |
thelancet.com | Elizabeth Gourd
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
-
May 1, 2024 |
thelancet.com | Elizabeth Gourd
The content on this site is intended for science and health care professionals. We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site. All content on this site: Copyright © 2024 Elsevier Ltd., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →